Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.

We have analysed the role of N-linked glycosylation in regulating human proteinase-activated receptor-2 (hPAR(2)) expression and function. Epitope-tagged wild-type hPAR(2) (wt-hPAR(2)) or hPAR(2) that lacked glycosylation sequons (following site-directed mutagenesis) in either the N-terminus [hPAR(2)N30A (Asn(30)-->Ala)], extracellular loop 2 [ECL2; hPAR(2)N222Q (Asn(222)-->Gln) or hPAR(2)N222A (Asn(222)-->Ala)] or both (hPAR(2)N30A,N222A or hPAR(2)N30A,N222Q) were expressed in the Chinese-hamster ovary (CHO) fibroblast cell line, Pro5. Western blot analysis of wt-hPAR(2) showed mature wt-hPAR(2) to have a molecular mass of 55-100 kDa, and 33-48 kDa following N -glycosidase F deglycosylation. FACS analysis and immunocytochemistry of the wt-hPAR(2) and PAR(2) mutant cell lines revealed that removal of both glycosylation sequons decreases (50% of wt-hPAR(2)) cell surface expression. Western blot analysis indicated that both N-linked sites are glycosylated. In functional studies, hPAR(2)N30A displayed a selective and significant increase in sensitivity towards tryptase. Interestingly, hPAR(2)N222A displayed a loss in sensitivity towards all PAR(2) agonists tested. However, further analysis revealed receptor sensitivity to alanine mutations in this domain, as the more conservative substitution hPAR(2)N222Q displayed no change in response to PAR(2) agonists. hPAR(2)N30A,N222Q displayed increased sensitivity towards tryptase, but a loss in sensitivity towards trypsin and the synthetic peptide SLIGRL-NH(2), although this loss in sensitivity towards trypsin and SLIGRL-NH(2) was secondary to changes in cell-surface expression. Finally, expression of sialic-acid-deficient wt-hPAR(2) in the CHO Lec2 glycosylation-deficient mutant cell line, showed a 40 kDa loss in molecular mass, in addition to a marked and selective increase in sensitivity towards tryptase. We conclude that hPAR(2) N-linked glycosylation and sialylation regulates receptor expression and/or signalling.

[1]  S. Coughlin,et al.  Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. , 1996, The Biochemical journal.

[2]  S. Coughlin,et al.  Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.

[3]  H. Kitagawa,et al.  Differential expression of five sialyltransferase genes in human tissues. , 1994, The Journal of biological chemistry.

[4]  B. Strömbeck,et al.  Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. , 1995, European journal of biochemistry.

[5]  J. Drazen,et al.  Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung* , 2001, The Journal of Biological Chemistry.

[6]  C. Napoli,et al.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Hollenberg,et al.  Contractile actions of proteinase‐activated receptor‐derived polypeptides in guinea‐pig gastric and lung parenchymal strips: evidence for distinct receptor systems , 2001, British journal of pharmacology.

[8]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[9]  Jennifer L. Harris,et al.  Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.

[10]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[11]  J. Axford.  Glycosylation and rheumatic disease. , 1999, Biochimica et biophysica acta.

[12]  A. Abou-Samra,et al.  Role of asparagine-linked oligosaccharides in the function of the rat PTH/PTHrP receptor. , 2000, Biochemistry.

[13]  R. Lavker,et al.  Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts , 1998, Journal of cellular physiology.

[14]  J. Hoxie,et al.  Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.

[15]  M. Nickerson.  Receptor Occupancy and Tissue Response , 1956, Nature.

[16]  M. Hollenberg,et al.  A Polymorphic Protease-activated Receptor 2 (PAR2) Displaying Reduced Sensitivity to Trypsin and Differential Responses to PAR Agonists* , 2000, The Journal of Biological Chemistry.

[17]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[18]  S. Holgate,et al.  The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. , 1998, Journal of immunology.

[19]  M. Hollenberg,et al.  Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Robert V Farese,et al.  A dual thrombin receptor system for platelet activation , 1998, Nature.

[21]  R. Young,et al.  Epitope tagging and protein surveillance. , 1991, Methods in enzymology.

[22]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Coughlin,et al.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Pouysségur,et al.  Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor (*) , 1995, The Journal of Biological Chemistry.

[25]  M. Hollenberg,et al.  Glycosylation and the activation of proteinase‐activated receptor 2 (PAR2) by human mast cell tryptase , 2001, British journal of pharmacology.

[26]  S. Austin,et al.  Glycosylation of the human prostacyclin receptor: role in ligand binding and signal transduction. , 2001, Molecular pharmacology.

[27]  C. Ponting,et al.  Concepts and principles of glycobiology , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  R. Reithmeier,et al.  Asparagine-linked oligosaccharides are localized to single extracytosolic segments in multi-span membrane glycoproteins. , 1994, The Biochemical journal.

[29]  P. Stanley,et al.  Translocation across golgi vesicle membranes: A CHO glycosylation mutant deficient in CMP-sialic acid transport , 1984, Cell.

[30]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[31]  M. Hollenberg,et al.  Proteinase activated receptor 2: role of extracellular loop 2 for ligand‐mediated activation , 1999, British journal of pharmacology.

[32]  S. Coughlin,et al.  Agonist Recognition by Proteinase-activated Receptor 2 and Thrombin Receptor , 1996, The Journal of Biological Chemistry.

[33]  R. Gerardy-Schahn,et al.  Mutants of the CMP-sialic Acid Transporter Causing the Lec2 Phenotype* , 1998, The Journal of Biological Chemistry.

[34]  R. Scarborough,et al.  Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. , 2000, Molecular pharmacology.

[35]  L. Miller,et al.  Role of N-linked glycosylation on the function and expression of the human secretin receptor. , 1999, Endocrinology.

[36]  D. Payan,et al.  Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* , 1996, The Journal of Biological Chemistry.

[37]  M. Hollenberg,et al.  International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.